Pension De-Risking Explained: Managing Longevity Risk

# Pension De-Risking Explained: How Sponsors Manage Longevity Risk Without Overpaying

By Jonas Osman Abdelghafour — Actuary & Risk Expert

Pension de-risking has moved from a niche corner of the insurance market to a boardroom priority. Corporate sponsors of defined benefit schemes have spent two decades discovering that running a pension plan is, in effect, running a small life insurance company on the side — one exposed to interest rates, inflation, equity markets, and the stubbornly uncertain question of how long members will live. De-risking is the process of shedding those exposures deliberately, rather than letting them shed you. What follows is a walk through what de-risking actually involves, why longevity risk is the hardest exposure to hedge, and how sponsors can sequence a journey without paying more than they need to.

A DB scheme promises members a defined income for life, and the sponsor bears everything that can go wrong with that promise: assets underperforming, discount rates falling and inflating the liability, inflation-linked benefits rising faster than expected, and members living longer than the mortality tables assumed. The last item deserves emphasis. Longevity risk is asymmetric and slow-burning. If a scheme's members live on average two years longer than assumed, liabilities can rise by roughly 6–8% depending on the scheme's maturity and benefit structure — and the error only reveals itself gradually, over decades. Unlike equity risk, you cannot diversify it away within the scheme, and unlike interest rate risk, you cannot hedge it cheaply with liquid instruments. That is why longevity sits at the centre of most serious de-risking conversations.

Pension de-risking isn't a single transaction but a spectrum of actions that escalate in cost, permanence, and completeness. The first step for most schemes is liability-driven investment: matching the interest rate and inflation sensitivity of assets to that of liabilities using bonds and swaps. LDI removes the funding-level volatility that comes from discount rate movements. It's cheap and reversible, but it does nothing about longevity — a fully hedged scheme can still watch its liabilities drift upward as mortality improvements outpace assumptions.

The next lever is member-facing. Options like enhanced transfer values, pension increase exchanges, or trivial commutation reduce the size and complexity of the liability by giving members choices about their benefits. Done well, with genuinely independent financial advice for members, these exercises shrink the problem before insuring it — and every pound of liability you remove is a pound you never pay an insurer's risk margin on.

Beyond that sit the risk-transfer instruments. A longevity swap transfers only the longevity component: the scheme pays a fixed leg based on expected pensioner payments plus a fee, and the counterparty pays the actual amounts as they fall due. If members live longer than expected, the counterparty absorbs the difference. Swaps suit large, well-funded schemes that want to keep their assets and investment strategy but cap the tail risk of mortality improvements. The trade-offs are collateral requirements, counterparty exposure, and the operational weight of a contract that may run for fifty years. A buy-in goes wider: the scheme purchases a bulk annuity from an insurer covering a subset of members, typically current pensioners. The policy is held as a scheme asset and pays cash flows that exactly match the insured benefits. Members see no change and the trustees retain responsibility, but investment, interest rate, inflation, and longevity risk are all removed for the covered population in one instrument — which is why pensioner buy-ins are often the workhorse of a de-risking journey. A buy-out is the endgame: the insurer takes on the liabilities directly, issues individual policies to members, and the scheme winds up. The sponsor's obligation ends entirely. Full buy-outs demand full funding on the insurer's pricing basis — which is more prudent than most ongoing funding bases — so the gap between where the scheme is funded and where the insurer prices is the central planning problem.

Bulk annuity pricing reflects the insurer's view of mortality, its investment strategy (often heavy in credit and illiquid assets), its capital requirements under regimes such as Solvency II, and market competition at the time of the transaction. Three practical lessons follow. Data quality is pricing power: insurers price uncertainty conservatively, and schemes that approach the market with clean membership data, verified marital statuses, and legally reviewed benefit specifications consistently obtain better pricing than schemes that leave insurers to guess. A data-cleansing exercise costing tens of thousands can move a transaction price by far more. Timing is opportunistic rather than schedulable: insurer appetite and pricing fluctuate with credit spreads, capital positions, and the volume of deals in the pipeline, and schemes that are transaction-ready — with governance, data, and a locked-down benefit specification in place — can move when pricing windows open. Schemes that start preparing after seeing attractive pricing usually miss it. And partial solutions carry residual risks worth naming: a pensioner buy-in leaves deferred members uninsured, and deferreds carry more longevity uncertainty because their benefits stretch further into the future; a longevity swap can complicate a later buy-in or buy-out, since the swap must be novated or unwound. Sequencing decisions taken today constrain the options available in ten years, and that deserves explicit analysis rather than an assumption that each step is independent.

Underneath every transaction sits a view on mortality: a base table reflecting current death rates for the scheme's population, plus an improvement assumption projecting how those rates will change. Small changes in the improvement assumption compound dramatically over long horizons. Sponsors should insist on understanding both components of their scheme's assumption, how it compares to the insurer's pricing basis, and how sensitive the transaction price is to each. An informed buyer negotiates; an uninformed one accepts.

Pension de-risking is best understood as a journey with an intended destination, not a series of opportunistic trades. The sensible sequence for most schemes is to hedge the market risks cheaply with LDI, shrink the liability through well-governed member options, insure the pensioner population when pricing allows, and target full buy-out once the funding gap on the insurer's basis has closed. Longevity risk is the thread running through all of it — the one exposure that neither markets nor time will hedge for you. Sponsors who invest early in data quality, transaction readiness, and a genuine understanding of their mortality assumptions consistently pay less for the same risk transfer.

---

Jonas Osman Abdelghafour is an actuary and risk expert advising insurers, pension schemes, and corporate sponsors on risk transfer, capital, and modelling. If your scheme is weighing a de-risking transaction — or you want an independent view on pricing, data readiness, or mortality assumptions — reach out at contact@jonasosman.org.